Disclosure of Ketamine Therapy for Depression at a Company Retreat Results in Termination of a Top Netflix Executive

Kevin Bailey's Dismissal

According to Evil HR Lady: Kevin Bailey, who served as Vice President and Head of Creative for Eyeline-a subsidiary fully owned by Netflix-was terminated after he openly discussed undergoing ketamine treatment for depression during a corporate retreat. The admission occurred in January 2026 as part of a “Trust-Vulnerability” exercise held at Sendero Ranch in Northern California, a property also owned by Netflix. According to a New York Post report, the decision to let Bailey go was partly triggered by his candid sharing of this medical treatment with colleagues. The incident has raised questions about how companies handle mental health disclosures in professional settings and whether fostering openness might carry unintended consequences.

This case underscores the delicate balance between personal health transparency and corporate expectations, while also prompting broader conversations about workplace support for depression and related challenges. The irony is that the very vulnerability exercise designed to build trust ultimately led to a termination, highlighting the risks employees face when sharing sensitive health information. As more organizations emphasize mental well-being, such events reveal persistent gaps between policy and practice in dealing with psychological struggles openly.